Arcellx
is a Maryland-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases... Read moreArcellx
is a Maryland-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases... Read more
2014
PublicAcquired by Gilead Sciences, Inc.NASDAQACLX
News
May 05, 2026
FierceBiotechIT
Arcellx: After Arcellx buyout close, Gilead trims 108 jobs at CAR-T biotech's Redwood City outpost.
May 02, 2026
Indian Pharma Post
Arcellx: Gilead completes $7.8B Arcellx acquisition & takes full control of Myeloma CAR-T candidate
Apr 30, 2026
Pharmabiz
Arcellx: Gilead Sciences completes acquisition of Arcellx ahead of commercial launch of Anitocel
Apr 08, 2026
Yahoo
Arcellx: Assessing Arcellx (ACLX) Valuation After Strong MultiYear Share Price Gains
Apr 01, 2026
Investing.com
Arcellx: Gilead extends Arcellx tender offer deadline to April 24
Mar 25, 2026
Pharamceutical Technology
Arcellx: Gilead doubles down on cell therapy: Inside the $7.8bn Arcellx acquisition
Mar 22, 2026
Investing.com
Arcellx: Arcellx earnings on deck ahead of Gilead acquisition close
Mar 16, 2026
Nasdaq
Arcellx: This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
Mar 09, 2026
Owler
Arcellx, Inc.: Arcellx's employee count changed from 163 in Dec 2024 to 209 in Dec 2025
Mar 08, 2026
Investing.com
Arcellx: Arcellx set to report earnings amid $7.8B Gilead deal
Arcellx Competitors
1
2
3
4
5
6